Triple
T2190624
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Remicade |
E49851
|
entity |
| Predicate | isCoDevelopedBy |
P6901
|
FINISHED |
| Object | Janssen Biotech |
E242407
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janssen Biotech | Statement: [Remicade, isCoDevelopedBy, Janssen Biotech]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Janssen Biotech Context triple: [Remicade, isCoDevelopedBy, Janssen Biotech]
-
A.
Janssen Biotech
chosen
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
B.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
C.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
D.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
E.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isCoDevelopedBy Context triple: [Remicade, isCoDevelopedBy, Janssen Biotech]
-
A.
isDevelopedBy
Indicates that something (such as a product, project, or idea) is created, produced, or brought into existence through the work or effort of a particular developer or group of developers.
-
B.
alsoDevelopedIn
Indicates that something was additionally developed in another context, location, or environment beyond the primary one already specified.
-
C.
coDeveloperOf
chosen
Indicates that two or more entities jointly developed or collaborated in creating the same project, product, or work.
-
D.
developedAs
Indicates that one entity was created, designed, or evolved specifically to function as or replace another entity.
-
E.
developedWith
Indicates that something was created, built, or produced using a specified tool, technology, method, or collaborator.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae65427de48190be3dbc9c0a888332 |
completed | March 9, 2026, 6:14 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
Created at: March 4, 2026, 7:46 p.m.